Package 25021-468-10

Brand: levothyroxine sodium

Generic: levothyroxine sodium anhydrous
NDC Package

Package Facts

Identity

Package NDC 25021-468-10
Digits Only 2502146810
Product NDC 25021-468
Product ID 25021-468_2662e418-ef9b-40be-abbd-db71401e3c20
Description

1 VIAL in 1 CARTON (25021-468-10) / 5 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2024-01-01
Brand levothyroxine sodium
Generic levothyroxine sodium anhydrous
Sample Package No

Linked Drug Pages (1)

Levothyroxine Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "2662e418-ef9b-40be-abbd-db71401e3c20", "openfda": {"unii": ["054I36CPMN"], "rxcui": ["966219", "1115267", "1115269"], "spl_set_id": ["f57e9b19-6f17-4520-80fc-511322cc56c9"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-468-10)  / 5 mL in 1 VIAL", "package_ndc": "25021-468-10", "marketing_start_date": "20240101"}], "brand_name": "Levothyroxine Sodium", "product_id": "25021-468_2662e418-ef9b-40be-abbd-db71401e3c20", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Thyroxine [CS]", "l-Thyroxine [EPC]"], "product_ndc": "25021-468", "generic_name": "Levothyroxine Sodium Anhydrous", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levothyroxine Sodium", "active_ingredients": [{"name": "LEVOTHYROXINE SODIUM ANHYDROUS", "strength": "100 ug/5mL"}], "application_number": "ANDA208749", "marketing_category": "ANDA", "marketing_start_date": "20240101", "listing_expiration_date": "20261231"}